Trials / Completed
CompletedNCT02580396
Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving Capecitabine
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This feasibility study will be conducted in order to provide proof of concept for the CanADVICE+® system comprising a smart phone app and a healthcare organization server side application based on Web 2 technologies. The main objective of this project is to optimise pharmaceutical counselling services by providing drug related information, in a digital format, to patients with metastatic breast cancer receiving Capecitabine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CanADVICE+® (smart phone app) | The main objective of this project is to optimise pharmaceutical counselling services by providing drug related information, in a digital format, to patients with metastatic breast cancer receiving Capecitabine. |
Timeline
- Start date
- 2016-03-16
- Primary completion
- 2018-11-01
- Completion
- 2018-11-01
- First posted
- 2015-10-20
- Last updated
- 2018-11-02
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02580396. Inclusion in this directory is not an endorsement.